P Touraine

Summary

Country: France

Publications

  1. pmc Hormonal status in protracted critical illness and in-hospital mortality
    Tarek Sharshar
    Department of Intensive Care Medicine, AP HP, Raymond Poincare Hospital, University Versailles Saint Quentin en Yvelines, 104 Bd Raymond Poincaré, Garches F 92380, France
    Crit Care 15:R47. 2011
  2. ncbi request reprint Breast inflammatory gigantomastia in a context of immune-mediated diseases
    P Touraine
    Department of Endocrinology and Reproductive Medicine, Hopital Necker, 149, rue de Sevres, 75743 Paris Cedex 15, France
    J Clin Endocrinol Metab 90:5287-94. 2005
  3. doi request reprint [Management of families at high risk for hereditary breast-ovarian cancers: the endocrinologist's point of view]
    C Courtillot
    Service d endocrinologie et médecine de la reproduction, Groupe Hospitalier Pitie Salpetriere, 47 83, Boulevard de l Hopital, 75013 Paris, France
    Ann Endocrinol (Paris) 69:193-200. 2008
  4. doi request reprint [Phenotype-genotype correlation in mutations of the gonadotrophin receptor gene in women]
    P Touraine
    Departement d Endocrinologie et Medecine de la Reproduction, Assistance Publique Hopitaux de Paris, Groupe Hospitalier Pitie Salpetriere, 75651 Paris Cedex 13, France
    Ann Endocrinol (Paris) 71:203-5. 2010
  5. doi request reprint Evaluation of different markers of the ovarian reserve in patients presenting with premature ovarian failure
    N Massin
    Department of Endocrinology and Reproductive Medicine, GH Pitié Salpêtrière 47 83, Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Mol Cell Endocrinol 282:95-100. 2008
  6. pmc Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors
    Roman L Bogorad
    Institut National de la Santé et de la Recherche Médicale U845, Equipe PRL, GH et Tumeurs, Centre de Recherche Croissance et Signalisation, F 75015 Paris, France
    Proc Natl Acad Sci U S A 105:14533-8. 2008

Collaborators

  • C Duflos
  • C Balleyguier
  • J C Carel
  • B Eymard
  • A May
  • C Courtillot
  • E Thibaud
  • Anne Gompel
  • Genevieve Plu-Bureau
  • Brigitte Sigal-Zafrani
  • Vincent Goffin
  • Tarek Sharshar
  • F Kuttenn
  • A Bachelot
  • Roman L Bogorad
  • N Massin
  • Kathleen Laborde
  • Herve Outin
  • Andrea Polito
  • Virginie Maxime
  • Sylvie Bastuji-Garin
  • Charles Cerf
  • Robert D Stevens
  • Bernard De Jonghe
  • Pablo Rodriguez
  • S Uzan
  • B Raccah Tebbeca
  • J Berdah
  • D Leger
  • A Perrin
  • Chidi Mestayer
  • J Caby
  • G Plu Bureau
  • K Clough
  • B Belaroussi
  • F Laki
  • G Caillaud
  • Jean Baptiste Jomain
  • J Viriot
  • J P Lefranc
  • N Chabbert Buffet
  • A Grimard
  • C Gracia
  • G Gibaud
  • H Hofman
  • J C Saiovici
  • S Yacoub
  • C Dhainault
  • M J Blin
  • M Misrahi
  • A Boudinet
  • G Meduri
  • C Chretien
  • B Sigal Zafrani
  • O Fiori
  • C Bricaire
  • M Sibout
  • I Denys
  • M Detoeuf
  • A Thoury
  • C Nos
  • Paul A Kelly
  • F Martinez
  • C Lanty
  • Frederique Kuttenn
  • M A Le Frere Belda
  • D Pelletier
  • J Bensimhon
  • C Hofman
  • H Charitanski
  • Lilya Harutyunyan
  • K Desthieux Ngo
  • J C Thalabard
  • Sophie Bernichtein
  • B Brethon
  • C Genestie
  • K B Triana Rabi
  • Anne Bachelot
  • G Delattre
  • L Meng
  • R Salmon

Detail Information

Publications6

  1. pmc Hormonal status in protracted critical illness and in-hospital mortality
    Tarek Sharshar
    Department of Intensive Care Medicine, AP HP, Raymond Poincare Hospital, University Versailles Saint Quentin en Yvelines, 104 Bd Raymond Poincaré, Garches F 92380, France
    Crit Care 15:R47. 2011
    ..The aim of this study was to determine the relationship between hormonal status and mortality in patients with protracted critical illness...
  2. ncbi request reprint Breast inflammatory gigantomastia in a context of immune-mediated diseases
    P Touraine
    Department of Endocrinology and Reproductive Medicine, Hopital Necker, 149, rue de Sevres, 75743 Paris Cedex 15, France
    J Clin Endocrinol Metab 90:5287-94. 2005
    ..Localized breast lesions have been described in lupic or diabetic patients. However, the description of breast gigantomastia in women presenting with autoimmune diseases has not been reported...
  3. doi request reprint [Management of families at high risk for hereditary breast-ovarian cancers: the endocrinologist's point of view]
    C Courtillot
    Service d endocrinologie et médecine de la reproduction, Groupe Hospitalier Pitie Salpetriere, 47 83, Boulevard de l Hopital, 75013 Paris, France
    Ann Endocrinol (Paris) 69:193-200. 2008
    ..It is best that counseling be given in an interdisciplinary cancer genetic clinic, where all practionners are aware of the latest data and guidelines...
  4. doi request reprint [Phenotype-genotype correlation in mutations of the gonadotrophin receptor gene in women]
    P Touraine
    Departement d Endocrinologie et Medecine de la Reproduction, Assistance Publique Hopitaux de Paris, Groupe Hospitalier Pitie Salpetriere, 75651 Paris Cedex 13, France
    Ann Endocrinol (Paris) 71:203-5. 2010
    ..The discovery of these mutations allows a better understanding of some genotypes and is helpful in advancing our knowledge of these receptors...
  5. doi request reprint Evaluation of different markers of the ovarian reserve in patients presenting with premature ovarian failure
    N Massin
    Department of Endocrinology and Reproductive Medicine, GH Pitié Salpêtrière 47 83, Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Mol Cell Endocrinol 282:95-100. 2008
    ..Finally, AMH levels in POF patients could identify women with persistent follicles...
  6. pmc Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors
    Roman L Bogorad
    Institut National de la Santé et de la Recherche Médicale U845, Equipe PRL, GH et Tumeurs, Centre de Recherche Croissance et Signalisation, F 75015 Paris, France
    Proc Natl Acad Sci U S A 105:14533-8. 2008
    ..Hallmarks of constitutive activity were all reversed by a specific PrlR antagonist, which opens potential therapeutic approaches for MFA, or any other disease that could be associated with this mutation in future...